Flanagan W. Michael Insider Trading Activity
Flanagan W. Michael has been net-selling over the last 12 months with 0 purchases and 4 sales across 1 company.
RNA is the most-traded position with 4 trades. The largest single transaction was a sale of RNA for $779K on Sep 11, 2025.
Performance Scorecard
Forward stock performance after each transaction by Flanagan W. Michael. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -4.7% | 20% | 5 |
| 90 days | — | +23.7% | 60% | 5 |
| 120 days | — | +21.2% | 60% | 5 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersRNA · Avidity Biosciences, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Flanagan W. Michael bought and sold RNA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jan 21, 2026 | RNA | Sell | 3,976 | $72.45 | $288K | −4.3% | Chief Scientific Officer | |
Jan 21, 2026 | RNA | Sell | 2,558 | $72.45 | $185K | −2.9% | Chief Scientific Officer | |
Jan 7, 2026 | RNA | Sell | 2,373 | $72.23 | $171K | −2.5% | Chief Scientific Officer | |
Sep 11, 2025 | RNA | Sell | 20,000 | $38.94 | $779K | −20.0% | Chief Scientific Officer | |
Jun 11, 2025 | RNA | Sell | 20,000 | $32.88 | $658K | −20.0% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| RNA | Avidity Biosciences, Inc. | 5 | $2.1M |
Other insiders at Avidity Biosciences, Inc.
7 other tracked filers at RNA.